Gc Cell Corp.
KOSDAQTotal Valuation
Gc Cell Corp. carries a market capitalization of 214.44B, placing it among publicly traded companies globally. Its enterprise value stands at 448.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 214.44B |
| Enterprise Value | 448.61B |
Share Statistics
Gc Cell Corp. currently has 15.03M shares outstanding.
| Shares Outstanding | 15.03M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 2.13, and the price-to-book ratio stands at 2.10.
| PE Ratio | N/A |
| PS Ratio | 2.13 |
| PB Ratio | 2.10 |
| P/TBV Ratio | 6.35 |
| P/FCF Ratio | 24.47 |
| P/OCF Ratio | 43.98 |
Enterprise Valuation
| EV / Sales | 2.75 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 23.59 |
Financial Position
Gc Cell Corp. maintains a current ratio of 0.53, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 51.94, indicating elevated leverage, while an interest coverage ratio of -2.81 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.53 |
| Quick Ratio | 0.00 |
| Debt / Equity | 51.94 |
| Debt / EBITDA | -7.35 |
| Interest Coverage | -2.81 |
Financial Efficiency
| Return on Equity (ROE) | -133.22 |
| Return on Assets (ROA) | -57.86 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 17.52 |
Taxes
| Income Tax | 5.33B |
| Effective Tax Rate | N/A |
Stock Price Statistics
Gc Cell Corp.'s stock has declined approximately -29.87715% over the past 52 weeks. The 50-day moving average sits at 19,452.40, while the 200-day moving average is 22,810.30.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29.87715% |
| 50-Day Moving Average | 19,452.40 |
| 200-Day Moving Average | 22,810.30 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Gc Cell Corp. generated 163.35B in revenue and converted that into -257.98B in net income, yielding earnings per share of -17,202.56. EBITDA reached -13.21B, while operating income came in at -13.21B.
| Revenue | 163.35B |
| Gross Profit | 28.34B |
| Operating Income | -13.21B |
| Pretax Income | -253.24B |
| Net Income | -257.98B |
| EBITDA | -13.21B |
| EBIT | -13.21B |
| Earnings Per Share (EPS) | -17,202.56 |
Balance Sheet
Gc Cell Corp. holds 464.98M in cash and equivalents against 97.13B in total debt, resulting in a net debt position of 69.04B. Total book value stands at 165.96B, with working capital of -46.06B providing operational flexibility.
| Cash & Cash Equivalents | 464.98M |
| Total Debt | 97.13B |
| Net Debt | 69.04B |
| Equity (Book Value) | 165.96B |
| Book Value Per Share | 11,041.17 |
| Working Capital | -46.06B |
Cash Flow
Gc Cell Corp. produced 7.91B in operating cash flow over the past twelve months. After subtracting -6.30B in capital expenditures, free cash flow totaled 1.61B - equivalent to 106.97 per share.
| Operating Cash Flow | 7.91B |
| Capital Expenditures | -6.30B |
| Free Cash Flow | 1.61B |
| FCF Per Share | 106.97 |
Margins
Gc Cell Corp. operates with a gross margin of 17.35, reflecting its pricing power and cost economics. The operating margin of -8.09 and net profit margin of -157.93 provide insight into operational efficiency.
| Gross Margin | 17.35 |
| Operating Margin | -8.09 |
| Pretax Margin | -155.03 |
| Profit Margin | -157.93 |
| EBITDA Margin | -8.09 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.61 |
| FCF Yield | 4.09 |
Scores
Gc Cell Corp. posts an Altman Z-Score of 3.09, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.09 |